The first few months of GLP-1 treatments felt encouraging. Your appetite quieted down and the scale kept moving in the direction you wanted. Then progress slowed, and now you’re wondering if something has changed. 

Before you decide what to do when GLP-1 stops working, it helps to know whether it actually has. A plateau after a strong start is common. GLP-1 receptor agonists (GLP-1 RAs), like Wegovy® and Ozempic®, work largely by signaling to your brain that you’re full and slowing how quickly your stomach empties, so you eat less and your body draws on stored energy. But how much weight you lose also depends on other factors, like your dose, daily habits, and hormones. Here’s how to tell what’s going on and what to do next.

‍

Why can GLP-1 weight loss slow or stop?

Trials show weight loss slowdown is the norm. In STEP 4, participants taking semaglutide lost roughly 11% of their body weight in the first 20 weeks, then about 8% more in the next 48 weeks. They lost less weight overall in twice as long a period.

So, do GLP-1s like Wegovy® stop working after a while? Not quite. The slowdown likely happens because millennia of food scarcity evolved your body to read weight loss as a threat. Fat cells release a hormone called leptin that tells your brain how much energy you’ve stored. As fat reserves shrink, leptin drops, and your body responds by releasing more ghrelin, a hormone that makes you hungry. Less leptin also leads to lower levels of thyroid hormone, which slows your metabolism. Your GLP-1 treatment keeps working against these mechanisms, but it can’t switch them off, which can lead to weight loss slowing.

At the same time, a smaller body requires less energy to run. So, even though you’re eating less, the calories you eat more closely match the calories you burn. That neutral energy balance also contributes to your weight loss plateau.

Several other factors can impact the plateau:

• Missed or lower doses: Skipping or stepping down to a lower dose, often to ease side effects, reduces the amount of medication in your body, weakening the brake on your appetite.
• Sleep and stress: Sleep deprivation makes you hungrier, and ongoing stress raises cortisol, a hormone that can fuel cravings for calorie-dense foods, making you eat more.
• Nutrition: Foods high in fat or sugar pack more calories into every bite. You might be taking in more calories than your small portions suggest.
• Hormones: During the menopause transition, falling estrogen makes losing muscle and gaining fat easier. Muscle burns about three times more calories at rest than fat. As muscle gives way to fat, your body reaches a neutral energy balance sooner.
• Physical activity: Your GLP-1 works mainly by lowering the calories you take in, not by burning more calories. If you’re more active, you’ll burn more calories in addition to eating less, maximizing your weight loss.

‍

How to tell if your GLP-1 is still working

The scale can be misleading. Weight naturally fluctuates one day to the next because of water retention and other reasons. Constipation, a common GLP-1 side effect, can also cause your weight to change. To get a more accurate picture of your progress, zoom out, consider the monthly trend, and look beyond the scale.

The clearest sign your treatment is still working is your appetite. In one 2020 study, people taking semaglutide ate about a third less in a meal. If smaller portions still satisfy you and food isn’t on your mind all day, your medication is likely still doing its job.

Your body offers other clues. Even if you’re not losing weight overall, pay attention to your waistline. A shrinking waist often means that you’re losing visceral fat, a type of fat stored around your organs. In one analysis, semaglutide cut visceral fat by about a quarter, more than it reduced fat overall. So it’s a positive sign if your waist is getting, or staying, smaller.

Also, GLP-1s stimulate insulin production, lower glucagon release, and slow digestion, all of which lower blood sugar. This effect is independent of weight loss. Have your blood sugar readings improved at checkups? Then your GLP-1 treatment is still working for you. 

If your weight loss progress has lost momentum, don’t assume your medication has failed. There are fixes available for the many possible causes for your slowdown.

What to do when your GLP-1 stops working for weight loss

If your weight loss has stagnated, your GLP-1 may have stopped working, but it also might be due to the factors listed above. The first step is to ask your clinician for a structured review of your treatment. A proper assessment checks everything from your current dosage to your medical history.

A 2025 joint advisory from four leading obesity and nutrition groups lays out everyday habits that give your medication its best chance to work for weight loss:

• Adequate protein: Protein keeps you satisfied for longer and protects your muscle, meaning you’ll eat less and burn more calories. The advisory suggests about 80 to 120 grams a day. Because your portions are smaller, aim to include some protein at every meal.
• Hydration: Constipation can hold up the scale and make progress seem stalled. Slower digestion allows your intestines to absorb more water from stool, leaving it dry and harder to pass. Drinking enough fluids keeps stool softer. The National Academies of Sciences, Engineering, and Medicine recommends about nine cups a day for women. 
• Movement: The advisory recommends at least 150 minutes of moderate activity, like brisk walking, a week, helping you burn more calories. 
• Strength training: Strength training at least three times per week helps ensure more of the weight you lose comes from fat instead of muscle.

In the meantime, ask your doctor before raising your dose, restarting after a break, or switching medications. Too much medication can lead to vomiting and dehydration severe enough to damage your kidneys, as well as pancreatitis or gallstones.

‍

When should you consider reassessing your GLP-1 treatment plan?

These are three scenarios in which it might be time to reassess your plan with your clinician.

Weight settled short of your goal

If you’ve addressed all the factors above and your weight won’t budge, your current plan may have taken you as far as it can. To go further, something must tip the energy balance again. 

One option is a higher dose. The FDA approved a 7.2 mg dose of Wegovy® for people who already hit a ceiling with the standard 2.4 mg. In trials, people on the 7.2 mg dose lost about 19% of their total body weight on average, compared with 16% on 2.4 mg. 

Another option is trying a different medication. In a head-to-head trial, people saw slower weight loss on semaglutide (around 14% of their weight) than people on tirzepatide (around 20%).

It may also be wise to revisit the goal itself. Health improvements often begin at a more modest 5% weight loss, so there might not be a need for you to lose any more weight beyond the plateau.

GLP-1 not working as expected

For roughly 1 in 10 people in clinical trials, GLP-1s produced less than 5% weight loss and little change to appetite, waist size, and blood sugar levels. Some also experienced appetite and weight return after an initial response. You could be in that 10%, but don’t judge too early. In one tirzepatide trial, 9 in 10 people who hadn’t lost 5% by week 12 reached it by week 72.

Researchers are still working out why this happens. People with type 2 diabetes tend to lose less weight—which may be a reason some people find themselves not losing weight on Ozempic® or other GLP-1s. And a 2026 study of about 28,000 people linked differences in the gene for the GLP-1 receptor to how much weight people lost. No single factor can yet predict response to GLP-1 treatment, though, so it’s worth trying a different dose or medication before stopping GLP-1s as a whole.

Treatment causing problems

Some people taking GLP-1s experience issues like muscle loss and severe side effects that outweigh the drugs' benefits. Your provider can check with a simple strength test or a body composition scan whether your weight loss is costing you too much muscle. If so, they’ll likely add more protein and strength training to your plan. If your muscle loss or other side effects remain even after fine-tuning, it’s a reasonable time to discuss other options. The right next step depends on your health history, long-term goals, and response to treatment.

‍

How Maven Clinic can help when GLP-1 progress stalls

A standstill doesn’t need to be the end of your progress. The key is finding what’s getting in the way. For that, you need a care team that understands all the factors that influence GLP-1 RA treatment efficiency and how they come together in your specific case. 

With Maven Clinic’s GLP-1 Care, you can meet metabolic and hormone health specialists who consider your life stage and hormonal history. We review your response to your medication, adjust your dose when clinically appropriate, and help you manage side effects. Meanwhile, nutrition and physical therapy consultations cover the habits that protect your progress. Book an appointment today.